WLD treatment significantly reduced myeloperoxidase (MPO) levels in the colon, indicating that WLD attenuated the intestinal inflammatory response in CDD rats (p < 0.01; Figure 2M). The gene discussed is MPO; the disease is craniodiaphyseal dysplasia.